Safder S Ganaie, Madeline M Schwarz, Cynthia M McMillen, David A Price, Annie X Feng, Joseph R Albe, Wenjie Wang, Shane Miersch, Anthony Orvedahl, Aidan R Cole, Monica F Sentmanat, Nawneet Mishra, Devin A Boyles, Zachary T Koenig, Michael R Kujawa, Matthew A Demers, Ryan M Hoehl, Austin B Moyle, Nicole D Wagner, Sarah H Stubbs, Lia Cardarelli, Joan Teyra, Anita McElroy, Michael L Gross, Sean P J Whelan, John Doench, Xiaoxia Cui, Tom J Brett, Sachdev S Sidhu, Herbert W Virgin, Takeshi Egawa, Daisy W Leung, Gaya K Amarasinghe, Amy L Hartman
{"title":"Lrp1 is a host entry factor for Rift Valley fever virus.","authors":"Safder S Ganaie, Madeline M Schwarz, Cynthia M McMillen, David A Price, Annie X Feng, Joseph R Albe, Wenjie Wang, Shane Miersch, Anthony Orvedahl, Aidan R Cole, Monica F Sentmanat, Nawneet Mishra, Devin A Boyles, Zachary T Koenig, Michael R Kujawa, Matthew A Demers, Ryan M Hoehl, Austin B Moyle, Nicole D Wagner, Sarah H Stubbs, Lia Cardarelli, Joan Teyra, Anita McElroy, Michael L Gross, Sean P J Whelan, John Doench, Xiaoxia Cui, Tom J Brett, Sachdev S Sidhu, Herbert W Virgin, Takeshi Egawa, Daisy W Leung, Gaya K Amarasinghe, Amy L Hartman","doi":"10.1016/j.cell.2021.09.001","DOIUrl":null,"url":null,"abstract":"<p><p>Rift Valley fever virus (RVFV) is a zoonotic pathogen with pandemic potential. RVFV entry is mediated by the viral glycoprotein (Gn), but host entry factors remain poorly defined. Our genome-wide CRISPR screen identified low-density lipoprotein receptor-related protein 1 (mouse Lrp1/human LRP1), heat shock protein (Grp94), and receptor-associated protein (RAP) as critical host factors for RVFV infection. RVFV Gn directly binds to specific Lrp1 clusters and is glycosylation independent. Exogenous addition of murine RAP domain 3 (mRAP<sub>D3</sub>) and anti-Lrp1 antibodies neutralizes RVFV infection in taxonomically diverse cell lines. Mice treated with mRAP<sub>D3</sub> and infected with pathogenic RVFV are protected from disease and death. A mutant mRAPD3 that binds Lrp1 weakly failed to protect from RVFV infection. Together, these data support Lrp1 as a host entry factor for RVFV infection and define a new target to limit RVFV infections.</p>","PeriodicalId":9656,"journal":{"name":"Cell","volume":" ","pages":"5163-5178.e24"},"PeriodicalIF":42.5000,"publicationDate":"2021-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8786218/pdf/nihms-1742896.pdf","citationCount":"38","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cell","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.1016/j.cell.2021.09.001","RegionNum":1,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2021/9/23 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 38
Abstract
Rift Valley fever virus (RVFV) is a zoonotic pathogen with pandemic potential. RVFV entry is mediated by the viral glycoprotein (Gn), but host entry factors remain poorly defined. Our genome-wide CRISPR screen identified low-density lipoprotein receptor-related protein 1 (mouse Lrp1/human LRP1), heat shock protein (Grp94), and receptor-associated protein (RAP) as critical host factors for RVFV infection. RVFV Gn directly binds to specific Lrp1 clusters and is glycosylation independent. Exogenous addition of murine RAP domain 3 (mRAPD3) and anti-Lrp1 antibodies neutralizes RVFV infection in taxonomically diverse cell lines. Mice treated with mRAPD3 and infected with pathogenic RVFV are protected from disease and death. A mutant mRAPD3 that binds Lrp1 weakly failed to protect from RVFV infection. Together, these data support Lrp1 as a host entry factor for RVFV infection and define a new target to limit RVFV infections.
期刊介绍:
Cells is an international, peer-reviewed, open access journal that focuses on cell biology, molecular biology, and biophysics. It is affiliated with several societies, including the Spanish Society for Biochemistry and Molecular Biology (SEBBM), Nordic Autophagy Society (NAS), Spanish Society of Hematology and Hemotherapy (SEHH), and Society for Regenerative Medicine (Russian Federation) (RPO).
The journal publishes research findings of significant importance in various areas of experimental biology, such as cell biology, molecular biology, neuroscience, immunology, virology, microbiology, cancer, human genetics, systems biology, signaling, and disease mechanisms and therapeutics. The primary criterion for considering papers is whether the results contribute to significant conceptual advances or raise thought-provoking questions and hypotheses related to interesting and important biological inquiries.
In addition to primary research articles presented in four formats, Cells also features review and opinion articles in its "leading edge" section, discussing recent research advancements and topics of interest to its wide readership.